Using co-immunoprecipitation (CO-IP), the study confirmed that FOXO4-DRI prevents FOXO4 binding to p53, facilitating phosphorylated p53 nuclear exclusion, which triggers BAX upregulation and cleaved caspase-3 activation driving selective apoptosis of senescent endothelial cells
The large amount doesn't pose a danger because people with pernicious anemia absorb only a small fraction of it
The votes were nonbinding, and final FDA action remained pending as of July 26, 2026
doi:10.1007/s00011-007-7056-8
Unlike pharmacological interventions that target single receptors or pathways, GHK-Cus multi-gene modulation touches many of the hallmarks of aging simultaneously: Genomic instability (DNA repair gene upregulation) Epigenetic alterations (chromatin remodeling via altered transcription factor activity) Loss of proteostasis (chaperone and proteasome pathway modulation) Cellular senescence (anti-apoptotic and anti-senescence gene networks) Altered intercellular communication (anti-inflammatory cytokine modulation) This positions GHK-Cu within what researchers increasingly call multi-hallmark peptide therapy a conceptual framework that prioritizes compounds acting across multiple aging mechanisms simultaneously
Due to its potent antioxidant activity, it combats oxidative stress in both the gastrointestinal tract and throughout the body, indicating further promise as a treatment for inflammatory diseases [2, 3, 4, 5, 6]
